Difference between revisions of "Fannin Innovation Studio"
Jump to navigation
Jump to search
imported>Komal |
imported>Komal |
||
| Line 6: | Line 6: | ||
==Application Criteria== | ==Application Criteria== | ||
| + | All companies in the Fannin portfolio are medical technology companies in the Texas Medical Center. Fannin Innovation Studio invests in these companies and works with them to take their ideas to market. The leaders of Fannin help co-found and manage the companies, in exchange for working space, networking resources, and investment money. One of the three members of the leadership team manages each portfolio company. Fannin helps its portfolio companies gain grant money, secure licensing, seek mentorship, and move into the next stage of development. [http://fannininnovation.com/how-we-work/for-inventors/] | ||
==Leadership Team== | ==Leadership Team== | ||
Revision as of 15:50, 14 March 2016
Contact
3900 Essex Lane, Suite 575 Houston, Texas 77027
Acceleration Program
Application Criteria
All companies in the Fannin portfolio are medical technology companies in the Texas Medical Center. Fannin Innovation Studio invests in these companies and works with them to take their ideas to market. The leaders of Fannin help co-found and manage the companies, in exchange for working space, networking resources, and investment money. One of the three members of the leadership team manages each portfolio company. Fannin helps its portfolio companies gain grant money, secure licensing, seek mentorship, and move into the next stage of development. [1]
Leadership Team
- Leo Linbeck III: Chairman and Founder, CEO of Aquinas Companies, LLC
- Dr. Atul Varadhachary, MD, PhD: Managing Partner
- Mark Worscheh: CFO, Executive VP of Aquinas Companies, LLC
Portfolio
- Accelerox
- ACF Pharmaceuticals
- Apaxis Medical
- Brevitest Technologies
- Clearview App
- Guidabot
- NewHeart
- Procyrion
- Pulmotect
